Buchumschlag

Blood phosphorylated Tau181 reliably differentiates amyloid‐positive from amyloid‐negative subjects in the Alzheimer's disease continuum: A systematic review and meta‐analysis

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Annibale Antonioni, Emanuela Maria Raho, Lamberto Manzoli, Giacomo Koch, Maria Elena Flacco, Francesco Di Lorenzo
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Characterizing Japanese older adults without dementia by amyloid PET status: A comparative study of amyloid‐positive and amyloid‐negative groups from Japanese trial‐ready cohort study
von: Saki Nakashima, et al.
Veröffentlicht: (2026)

Development of amyloid‐negative neuropsychological norms using GAMLSS
von: Sara Rubio‐Guerra, et al.
Veröffentlicht: (2025)

Clinical and MRI features associated with amyloid positivity in secondary screening for anti–amyloid‐β therapy
von: Kazuki Yamada, et al.
Veröffentlicht: (2026)

Faster decline of very prodromal dementia with Lewy bodies when amyloid positive
von: Frédéric Blanc, et al.
Veröffentlicht: (2025)

Multi‐modal machine learning for predicting amyloid positivity using on‐ramp driving
von: Sai Santosh Reddy Danda, et al.
Veröffentlicht: (2025)

Inner and outer retinal abnormalities detected in Alzheimer's disease subjects diagnosed by amyloid PET not revealed when classified based on clinical criteria
von: Leonardo E. Ariello, et al.
Veröffentlicht: (2025)

The relationship between cognitive screeners and everyday functioning in amyloid‐positive participants from the Amsterdam Dementia Cohort
von: Angela van der Putten‐Toorenburg, et al.
Veröffentlicht: (2026)

Intracranial arteriosclerosis is not associated with cerebral amyloid deposition
von: Anna M. Streiber, et al.
Veröffentlicht: (2024)

Social relationships, amyloid burden, and dementia: The ARIC‐PET study
von: Renée C. Groechel, et al.
Veröffentlicht: (2024)

Factors associated with discordant visual and quantitative amyloid PET results
von: Jasmin E Guevara, et al.
Veröffentlicht: (2026)

Input of exome sequencing in early‐onset cerebral amyloid angiopathy
von: Lou Grangeon, et al.
Veröffentlicht: (2024)

Patients’ choices and eligibility for anti‐amyloid therapy in Japan's universal insurance
von: Ryoko Ihara, et al.
Veröffentlicht: (2026)

Motor, not cognitive, performance relates to amyloid status in normal older adults
von: Amanda Cook Maher, et al.
Veröffentlicht: (2026)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
von: Soheil Mohammadi, et al.
Veröffentlicht: (2025)

Eligibility for anti‐amyloid treatment in a multiethnic community‐based study
von: Lydia Trudel, et al.
Veröffentlicht: (2026)

White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies
von: Antoine Garnier‐Crussard, et al.
Veröffentlicht: (2026)

Clinical and demographic factors modify the association between plasma phosphorylated tau‐181 and cognition
von: Corey J. Bolton, et al.
Veröffentlicht: (2024)

A systematic review and meta‐analysis of dual‐task outcomes in subjective cognitive decline
von: Talia Salzman, et al.
Veröffentlicht: (2025)

Hallucinations and delusions are associated with elevated tau PET signal independent of age, clinical severity, and amyloid burden
von: Aubrey S Johnson, et al.
Veröffentlicht: (2026)

Lecanemab and amyloid‐related imaging abnormalities: Real‐world data from a single center experience
von: Alexander Wallace, et al.
Veröffentlicht: (2026)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
von: Xiang‐Sha Yin, et al.
Veröffentlicht: (2025)

Investigating the amyloid–tau–neurodegeneration framework in Alzheimer's disease using semi‐supervised multimodal imaging data fusion
von: You Cheng, et al.
Veröffentlicht: (2026)

Body composition and plasma total‐tau, neurofilament light chain, and amyloid‐β: A population‐based study
von: Tosca O. E. de Crom, et al.
Veröffentlicht: (2024)

The impact of amyloid beta burden on white matter dysfunction and associated transcriptomic signatures in cognitively normal elderly individuals
von: Ziyun Li, et al.
Veröffentlicht: (2025)

Standardization of criteria in MacCAT‐T and MacCAT‐CR for monoclonal anti–beta‐amyloid antibodies: A Delphi study
von: Jonas Karneboge, et al.
Veröffentlicht: (2025)

Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort
von: Joyce R. Chong, et al.
Veröffentlicht: (2024)

Suboptimal self‐reported sleep efficiency and duration are associated with faster accumulation of brain amyloid beta in cognitively unimpaired older adults
von: Louise N. Pivac, et al.
Veröffentlicht: (2024)

Lower odor identification in subjective cognitive decline: a meta‐analysis
von: Benoît Jobin, et al.
Veröffentlicht: (2025)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
von: Faheem Arshad, et al.
Veröffentlicht: (2025)

Plasma amyloid‐β oligomerization tendency as a potential predictor for conversion from mild cognitive impairment to Alzheimer's dementia: Findings from the GMCII cohort
von: Yuhan Xie, et al.
Veröffentlicht: (2025)

Novel insights into early Alzheimer's disease: quantitative gradient recalled echo MRI reveals preatrophic neuronal and myelin injury concurrent with emerging amyloid pathology
von: Satya V. V. N. Kothapalli, et al.
Veröffentlicht: (2026)

The prognosis of mild cognitive impairment: A systematic review and meta‐analysis
von: Simone Salemme, et al.
Veröffentlicht: (2025)

A systematic review and meta‐analysis of basal microbiota and cognitive function in Alzheimer's disease: A potential target for treatment or a contributor to disease progression?
von: Ana Maria Jimenez‐García, et al.
Veröffentlicht: (2024)

Preclinical dementia rating scores are associated with plasma phosphorylated tau‐217
von: Qi Huang, et al.
Veröffentlicht: (2025)

Cross‐sectional study of plasma phosphorylated tau 217 in persons without dementia
von: Toni T. Saari, et al.
Veröffentlicht: (2025)

Impact of dual sensory impairment on dementia: A systematic review and meta‐analysis
von: Daniele Urso, et al.
Veröffentlicht: (2026)

Correction to “The prognosis of mild cognitive impairment: A systematic review and meta‐analysis”
Veröffentlicht: (2025)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
von: Miguel Ángel Rivas‐Fernández, et al.
Veröffentlicht: (2026)

Accuracy of clinical diagnosis of behavioral variant frontotemporal dementia: A systematic review and meta‐analysis
von: Daniele Urso, et al.
Veröffentlicht: (2026)

Amyloid‐related changes in fluency in patients with subjective cognitive decline
von: Rosanne L. van den Berg, et al.
Veröffentlicht: (2025)